Keywords: medarex, starts, arthritis, antibody, trials, mdx-cd4, entered

Medarex starts arthritis antibody trials

Article | 11 February 1999

Print This

- Medarex' MDX-CD4 has entered Phase I trials for the treatment ofrheumatoid arthritis. It is the company's first entirely human antibody ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in